These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1716541)

  • 1. CD5+ B cells and naturally occurring autoantibodies in cancer patients.
    Stein R; Witz IP; Ovadia J; Goldenberg DM; Yron I
    Clin Exp Immunol; 1991 Sep; 85(3):418-23. PubMed ID: 1716541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects.
    Schatz DA; Lang F; Cantor AB; Riley WJ; Maclaren NK; Sleasman JW; Barrett DJ
    Diabetes; 1991 Oct; 40(10):1314-8. PubMed ID: 1718800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in peripheral blood CD5 (Bla) B-cell populations and autoantibodies following blood transfusion.
    Paglieroni TG; Ward J; Holland PV
    Transfusion; 1995 Mar; 35(3):189-98. PubMed ID: 7533341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of CD5+ B lymphocytes in the peripheral blood of patients with myasthenia gravis.
    Ragheb S; Lisak RP
    Neurology; 1990 Jul; 40(7):1120-4. PubMed ID: 1694020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5-positive B cells in type 1 (insulin-dependent) diabetic children.
    Lorini R; Massa M; d'Annunzio G; Cortona L; De Benedetti F; Martini A; Severi F
    Diabetes Res Clin Pract; 1993 Jan; 19(1):17-22. PubMed ID: 7682495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis. The Leishmania Study Group.
    Louzir H; Belal-Kacemi L; Sassi A; Laouini D; Ben Ismail R; Dellagi K
    Clin Exp Immunol; 1994 Mar; 95(3):479-84. PubMed ID: 7511080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CD5-positive B lymphocytes in type I diabetes.
    Muñoz A; Gallart T; Viñas O; Gomis R
    Clin Exp Immunol; 1991 Feb; 83(2):304-8. PubMed ID: 1704297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some patients with primary antiphospholipid syndrome have increased circulating CD5+ B cells that correlate with levels of IgM antiphospholipid antibodies.
    Velasquillo MC; Alcocer-Varela J; Alarcón-Segovia D; Cabiedes J; Sánchez-Guerrero J
    Clin Exp Rheumatol; 1991; 9(5):501-5. PubMed ID: 1720070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells expressing CD5 antigen are markedly increased in peripheral blood and spleen lymphocytes from patients with immune thrombocytopenic purpura.
    Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S
    Br J Haematol; 1991 Aug; 78(4):474-9. PubMed ID: 1716955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5+ B-cells at the onset of type I diabetes and in the prediabetic period.
    Smerdon RA; Peakman M; Hussain MJ; Wong FS; Watkins PJ; Leslie RD; Vergani D
    Diabetes Care; 1994 Jul; 17(7):657-64. PubMed ID: 7523048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5+ B lymphocytes and T-cell subsets in a case of juvenile rheumatoid arthritis.
    Ambrogi F; Ricciardi L; Nutini P; Vanacore R
    Ann N Y Acad Sci; 1992 May; 651():564-9. PubMed ID: 1376077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects.
    Ganguli R; Rabin BS
    Psychiatry Res; 1993 Jul; 48(1):69-78. PubMed ID: 7692460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
    Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
    Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.
    Ekerfelt C; Ernerudh J; Solders G; Vrethem M
    Clin Exp Immunol; 1995 Aug; 101(2):346-50. PubMed ID: 7544252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome.
    van de Merwe JP; van den Beemd MW; Hooijkaas H
    Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the expression of CD5 by human B cells and correlation with functional activity.
    Vernino LA; Pisetsky DS; Lipsky PE
    Cell Immunol; 1992 Jan; 139(1):185-97. PubMed ID: 1370255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ontogeny and functional characteristics of human B-1 (CD5+ B) cells.
    Bhat NM; Kantor AB; Bieber MM; Stall AM; Herzenberg LA; Teng NN
    Int Immunol; 1992 Feb; 4(2):243-52. PubMed ID: 1377947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals.
    Yi Q; Ahlberg R; Pirskanen R; Lefvert AK
    Neurology; 1992 May; 42(5):1081-4. PubMed ID: 1374547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CD5+CD19+ B lymphocytes at the onset of type 1 diabetes in children.
    De Filippo G; Pozzi N; Cosentini E; Cavalcanti M; Carel JC; Tamasi S; Franzese A; Pignata C
    Acta Diabetol; 1997 Dec; 34(4):271-4. PubMed ID: 9451471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.
    Indraccolo S; Mion M; Zamarchi R; Veronesi A; Veronese ML; Panozzo M; Betterle C; Barelli A; Borri A; Amadori A
    J Clin Immunol; 1993 Nov; 13(6):381-8. PubMed ID: 7507125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.